These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2569507)

  • 1. Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study.
    Wolf ME; Zigmond MJ; Kapatos G
    J Neurochem; 1989 Sep; 53(3):879-85. PubMed ID: 2569507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis and isolation of permeabilized dopamine nerve terminals from rat striatum.
    Wolf ME; Kapatos G
    J Neurosci; 1989 Jan; 9(1):106-14. PubMed ID: 2563275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL; Keller RW; Zigmond MJ
    J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine hydroxylase phosphorylation in rat brain striatal synaptosomes.
    Colby KA; Thompson TL; Patrick RL
    Brain Res; 1989 Jan; 478(1):103-11. PubMed ID: 2564295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of rat striatal nerve terminals.
    Wolf ME; Kapatos G
    J Neurosci; 1989 Jan; 9(1):94-105. PubMed ID: 2563283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E; Hefti F; Wurtman RJ
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the distribution of G alpha o in rat striatal synaptosomes and its colocalization with tyrosine hydroxylase.
    Wolf ME; Granneman JG; Kapatos G
    Synapse; 1991 Sep; 9(1):66-74. PubMed ID: 1686673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.
    Muñoz AM; Rey P; Soto-Otero R; Guerra MJ; Labandeira-Garcia JL
    J Neurosci Res; 2004 May; 76(4):551-62. PubMed ID: 15114627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis.
    Levine RA; Miller LP; Lovenberg W
    Science; 1981 Nov; 214(4523):919-21. PubMed ID: 6117945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. Multiple-site phosphorylation in vivo and in synaptosomes.
    Haycock JW; Haycock DA
    J Biol Chem; 1991 Mar; 266(9):5650-7. PubMed ID: 1672315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor activates tyrosine hydroxylase in rat and mouse striatal homogenates.
    Olianas MC; Onali P
    Eur J Pharmacol; 1988 Jun; 150(3):389-92. PubMed ID: 2901359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis.
    Carder RK; Jackson D; Morris HJ; Lund RD; Zigmond MJ
    Exp Neurol; 1989 Sep; 105(3):251-9. PubMed ID: 2569987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate.
    Wolf ME; LeWitt PA; Bannon MJ; Dragovic LJ; Kapatos G
    J Neurochem; 1991 Apr; 56(4):1191-200. PubMed ID: 1672141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism.
    Zigmond MJ; Acheson AL; Stachowiak MK; Stricker EM
    Arch Neurol; 1984 Aug; 41(8):856-61. PubMed ID: 6147127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.
    Waggoner WG; McDermed J; Leighton HJ
    Mol Pharmacol; 1980 Jul; 18(1):91-9. PubMed ID: 6106156
    [No Abstract]   [Full Text] [Related]  

  • 17. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
    O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
    Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.
    Blanchard V; Chritin M; Vyas S; Savasta M; Feuerstein C; Agid Y; Javoy-Agid F; Raisman-Vozari R
    J Neurochem; 1995 Apr; 64(4):1669-79. PubMed ID: 7891094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis.
    Onn SP; Berger TW; Stricker EM; Zigmond MJ
    Brain Res; 1986 Jun; 376(1):8-19. PubMed ID: 3087584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y; Okamura H; Matsumoto Y; Nagatsu I; Ibata Y
    Brain Res; 1991 May; 549(2):350-3. PubMed ID: 1679369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.